|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net earnings | |||||
| Adjustments to reconcile earnings to cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Stock based compensation expense | |||||
| Deferred income taxes | |||||
| Non-cash impairments | |||||
| Pension settlement income | |||||
| Pension settlement non-cash taxes | |||||
| Net changes in operating assets and liabilities, net of acquisitions: | |||||
| Current assets and liabilities | |||||
| Noncurrent assets and liabilities | |||||
| Cash Provided by Operating Activities | |||||
| Investing Activities | |||||
| Capital expenditures | |||||
| Acquisitions | |||||
| Investments in marketable securities | |||||
| Net proceeds from sales of marketable securities | |||||
| Cash Used in Investing Activities | |||||
| Financing Activities | |||||
| Long-term debt incurred (repaid) | |||||
| Proceeds from debt | |||||
| Repayments of debt | |||||
| Total long-term debt incurred (repaid) | |||||
| Common stock repurchases | |||||
| Net proceeds from stock option activity | |||||
| Dividends paid | |||||
| Cash Used in Financing Activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents-beginning of year | |||||
| Cash and Cash Equivalents-End of Year | |||||
Loading...
